Protagenic Therapeutics reprices outstanding stock options to $0.2655 per share

Protagenic Therapeutics, Inc.new

Stockholders approved repricing of options under 2006 and 2016 Equity Incentive Plans.
Original exercise prices ranged from $1.74 to $19.92; repriced to $0.2655 per share.
New exercise price equals closing common stock price on February 21, 2025.
Action intended to retain and incentivize option holders, including officers and employees.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.